F. Virzi

1.0k total citations
21 papers, 829 citations indexed

About

F. Virzi is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, F. Virzi has authored 21 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Cell Biology. Recurrent topics in F. Virzi's work include Radiopharmaceutical Chemistry and Applications (16 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Biotin and Related Studies (5 papers). F. Virzi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (16 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Biotin and Related Studies (5 papers). F. Virzi collaborates with scholars based in United States, Sweden and Italy. F. Virzi's co-authors include D.J. Hnatowich, Mary Rusckowski, P.W. Doherty, Miklos C. Fogarasi, Paul Winnard, Purtilo Dt, Donald J. Hnatowich, G Mardirossian, Cassandra L. Smith and Paul T. Winnard and has published in prestigious journals such as JAMA, Tetrahedron Letters and Journal of Immunological Methods.

In The Last Decade

F. Virzi

21 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Virzi United States	11	542	217	177	117	100	21	829
F Searle United Kingdom	19	767 1.4×	685 3.2×	334 1.9×	78 0.7×	33 0.3×	52	1.4k
RHJ Begent United Kingdom	14	377 0.7×	233 1.1×	131 0.7×	48 0.4×	23 0.2×	18	564
T. Ghose Canada	20	493 0.9×	350 1.6×	274 1.5×	153 1.3×	19 0.2×	55	1.1k
Shuping Dou United States	18	457 0.8×	303 1.4×	130 0.7×	82 0.7×	18 0.2×	47	769
D. A. DARCY United Kingdom	14	249 0.5×	229 1.1×	250 1.4×	97 0.8×	30 0.3×	25	764
Earl F. Albone United States	17	180 0.3×	294 1.4×	241 1.4×	61 0.5×	23 0.2×	35	729
RG Melton United Kingdom	12	368 0.7×	414 1.9×	190 1.1×	31 0.3×	40 0.4×	17	748
Sidney Bennett United States	17	1.0k 1.9×	424 2.0×	424 2.4×	196 1.7×	32 0.3×	24	1.4k
Laura Meléndez‐Alafort Italy	19	597 1.1×	205 0.9×	360 2.0×	232 2.0×	64 0.6×	75	1.2k
Tetsuo Nakashima Japan	13	287 0.5×	121 0.6×	144 0.8×	99 0.8×	9 0.1×	28	545

Countries citing papers authored by F. Virzi

Since Specialization

Citations

This map shows the geographic impact of F. Virzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Virzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Virzi more than expected).

Fields of papers citing papers by F. Virzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Virzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Virzi. The network helps show where F. Virzi may publish in the future.

Co-authorship network of co-authors of F. Virzi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Virzi. A scholar is included among the top collaborators of F. Virzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Virzi. F. Virzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Virzi, F., Paul Winnard, Miklos C. Fogarasi, et al.. (1995). Recombinant Metallothionein-Conjugated Streptavidin Labeled with 188Re and 99mTc. Bioconjugate Chemistry. 6(1). 139–144. 7 indexed citations

Hnatowich, Donald J., Paul T. Winnard, F. Virzi, et al.. (1995). Technetium-99m labeling of DNA oligonucleotides.. PubMed. 36(12). 2306–14. 59 indexed citations

Rusckowski, Mary, Miklos C. Fogarasi, F. Virzi, & D.J. Hnatowich. (1995). Influence of endogenous biotin on the biodistribution of labelled biotin derivatives in mice. Nuclear Medicine Communications. 16(1). 38–46. 10 indexed citations

Virzi, F., et al.. (1994). Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?. Nuclear Medicine and Biology. 21(8). 1035–1044. 39 indexed citations

Hnatowich, Donald J., F. Virzi, Paul T. Winnard, Miklos C. Fogarasi, & Mary Rusckowski. (1994). Investigations of ascorbate for direct labeling of antibodies with technetium-99m.. PubMed. 35(1). 127–34. 7 indexed citations

Hnatowich, D.J., Paul Winnard, F. Virzi, et al.. (1994). AMPLIFICATION OF RADIOACTIVITY USING COMPLEMENTARY DNA CONJUGATES. Journal of Immunotherapy. 16(2). 158–158. 3 indexed citations

Virzi, F.. (1994). Signs of Life: The Language and Meaning of DNA. JAMA. 271(18). 1457–1457. 8 indexed citations

Mardirossian, G, et al.. (1993). Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.. PubMed. 34(1). 109–19. 52 indexed citations

Hnatowich, D.J., B A Fritz, F. Virzi, G Mardirossian, & Mary Rusckowski. (1993). Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nuclear Medicine and Biology. 20(2). 189–195. 19 indexed citations

10.

Wu, Chao‐Liang, F. Virzi, & D.J. Hnatowich. (1992). Investigations of N-linked macrocycles for 111in and 90Y labeling of proteins. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(2). 239–244. 8 indexed citations

11.

Virzi, F., et al.. (1991). New indium-111 labeled biotin derivatives for improved immunotargeting. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(7). 719–726. 11 indexed citations

12.

Misra, Hemant, et al.. (1989). Synthesis of a novel diaminodithiol ligand for labeling proteins and small molecules with technetium-99m. Tetrahedron Letters. 30(15). 1885–1888. 8 indexed citations

13.

Hnatowich, D.J., F. Virzi, Paul W. Doherty, et al.. (1987). Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi. European Journal of Nuclear Medicine and Molecular Imaging. 13(9). 467–73. 13 indexed citations

14.

Virzi, F., et al.. (1987). Serum stability and non-specific binding of technetium-99m labeled diaminodithiol for protein labeling. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 14(6). 555–561. 8 indexed citations

15.

Hnatowich, D.J., F. Virzi, & Mary Rusckowski. (1987). Investigations of avidin and biotin for imaging applications.. PubMed. 28(8). 1294–302. 333 indexed citations

16.

Virzi, F., et al.. (1987). The use of diaminodithiol for labeling small molecules with technetium-99m. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 14(1). 63–67. 7 indexed citations

17.

Virzi, F., et al.. (1985). Indium-111 labeled tissue plasminogen activator. 26(5). 21. 8 indexed citations

18.

Rusckowski, Mary, Paul W. Doherty, F. Virzi, & Donald J. Hnatowich. (1985). A simple in vitro method of screening panels of monoclonal antibodies for tumor binding. Journal of Immunological Methods. 76(2). 375–382. 4 indexed citations

19.

Hnatowich, D.J., F. Virzi, & P.W. Doherty. (1985). DTPA-coupled antibodies labeled with yttrium-90.. PubMed. 26(5). 503–9. 132 indexed citations

20.

Dt, Purtilo, et al.. (1979). Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome.. PubMed. 16(4). 309–43. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact